Apimeds Pharmaceuticals US Inc.
10/16/2025 | Press release | Distributed by Public on 10/16/2025 14:16
Amendments to Bylaws (Form 8-K)
Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
On October 15, 2025, the board of directors of Apimeds Pharmaceuticals US, Inc. (the "Company") amended the bylaws to allow shareholder action by written consent.
The foregoing description of the Amendments does not purport to be complete and is qualified in its entirety by reference to the full text of the form of the Amendment, a copy of which is filed as Exhibit 3.1 to this Current Report on Form 8-K and incorporated herein by reference.
Apimeds Pharmaceuticals US Inc. published this content on October 16, 2025, and is solely responsible for the information contained herein. Distributed via EDGAR on October 16, 2025 at 20:16 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]